During early mouse embryogenesis, fetal liver kinase-1 (Flk-1), a receptor for vascular endothelial growth factor, and Runx1, a runt domain transcription factor, have prerequisite roles in the generation of hematopoietic lineages. Flk-1 expression is maintained in successive stages from mesodermal to endothelial cells and is down-regulated in nascent hematopoietic cells, whereas Runx1 (Runt-related transcription factor 1) is expressed in embryonic sites of hematopoietic cell de novo generation and in practically all hematopoietic organs. Here we show that Runx1 represses Flk-1 during the development of hemogenic endothelial cells into hematopoietic cells. We established embryonic stem cell clones carrying the Venus gene, a modified version of yellow fluorescence protein, in the Runx1 locus and cultured them on 0139 cells. Flk-1(+) cells appeared on day 3.5, and Runx1(+) cells first appeared from the Flk-1(+) fraction on day 4.5. The Flk-1(+)Runx1(+) cells rapidly stopped expressing Flk-1 with further incubation and eventually gave rise to CD45(+) or TER119(+) cells. Runx1 repressed Flk-1 promoter transcriptional activity in an endothelial cell line, and this repression required intact DNA-binding and transactivating domains of Runx1 protein. The repressor activity of Runx1 on endogenous Flk-1 was also confirmed by overexpressing Runx1 in embryonic stem cell differentiation cultures. These results provide novel insight into the role of Runx1 during the development of hematopoietic cell lineages.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据